कोशिश गोल्ड - मुक्त
Novo moves HC to restrain Sun Pharma
Mint New Delhi
|December 10, 2025
As blockbuster weight loss drug semaglutide inches closer to losing its patent exclusivity in India, innovator Novo Nordisk is upping its ante against local firms wanting to launch copies of the drug.
The Danish drugmaker on Tuesday moved the Delhi High Court, seeking to restrain domestic giant Sun Pharmaceutical Industries from launching its generic version of semaglutide, a widely prescribed drug for diabetes and weight loss.
The matter was heard briefly by a bench headed by justice Tejas Karia, who transferred the case to the bench already hearing Novo's parallel litigation against Dr. Reddy’s Laboratories and Natco Pharma concerning the same patent.
The plea is likely to be taken up today before justice Manmeet Pritam Singh Arora, who last week allowed Dr. Reddy's Laboratories to export semaglutide to non-patent nations.
यह कहानी Mint New Delhi के December 10, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint New Delhi से और कहानियाँ
Mint New Delhi
Dirty air trick: How farmers outsmart vigil
Farmers in Punjab and Haryana are burning paddy stubble late in the day after monitoring satellites pass over, says a study by the International Forum for Environment, Sustainability and Technology (iForest), released on 8 December. Mint brings the perspectives.
2 mins
December 11, 2025
Mint New Delhi
TCS inks $700 mn deal for US tech co
Tata Consultancy Services (TCS) on Wednesday made its largest buyout since going public in 2004, agreeing to acquire technology consulting firm Coastal Cloud for $700 million in cash.
2 mins
December 11, 2025
Mint New Delhi
An FDI revival
Outflows of \"hot money\" from India's stock market and a fast weakening rupee may have caused some anxiety this year, but the outlook on foreign direct investment (FDI) has brightened.
1 min
December 11, 2025
Mint New Delhi
IndiGo may see 10% revenue hit
A ten-day turmoil and a compulsory flight reduction will slam the financials of IndiGo, three equity analysts said, even as the regulator stepped up scrutiny of India's largest airline.
3 mins
December 11, 2025
Mint New Delhi
Amazon bets $35 billion more on India business
Total India investments to top $75 bn; Cloud, AI, exports and jobs in focus
3 mins
December 11, 2025
Mint New Delhi
MALHOTRA AT HELM: DID HE GIVE IT ALL?
Sanjay Malhotra's first year as RBI governor was marked by a favourable inflation-growth cycle, which he used to front load rate cuts and ease liquidity amid global uncertainties, while allowing the rupee to depreciate.
3 mins
December 11, 2025
Mint New Delhi
Suzlon’s growth runway needs help from solid execution
Suzlon Energy Ltď'sstock is down about 25% over the past six months, weighed down by the fear that India's wind cycle is losing momentum.
1 mins
December 11, 2025
Mint New Delhi
Over 500,000 flee renewed Thailand, Cambodia clashes
President Donald Trump plans to speak to the leaders of Thailand and Cambodia as more than half a million people flee a revived border clash, one of eight conflicts the US leader has claimed credit for ending.
1 mins
December 11, 2025
Mint New Delhi
ICICI Pru AMC IPO to test group’s listing luck
As India's capital markets expand and household savings accelerate their shift toward financial products, asset management companies are entering a new phase of growth, powered by rising retail participation and record flows into systematic investment plans (SIPs).
2 mins
December 11, 2025
Mint New Delhi
Regulator opens $177 bn pension pool to wider investments
India’s pension regulator has broadened investment opportunities for National Pension System (NPS) fund managers, allowing deeper participation in equities, bonds and alternative assets as part of a sweeping update to investment norms.
1 min
December 11, 2025
Listen
Translate
Change font size